Introduction
For a growing insurer, ORSA governance is tested when strategy changes faster than established processes can keep pace. A board may receive a polished report and still lack the information needed to challenge expansion, understand who owns its assumptions, or decide what to do if the plan strains the insurer’s capital objectives. Effective governance makes those responsibilities and decision links explicit.
This case uses a hypothetical insurer to examine who should do what, what the board should ask, and how the ORSA should inform a strategic choice. The emphasis is governance, not constructing a risk inventory, calculating a solvency baseline, or designing stress tests.
The Case: Northstar Mutual
Northstar Mutual is a hypothetical regional insurer considering rapid growth through a new commercial product and a digital distribution partnership. Its board has approved an internal capital objective: maintain a projected capital-to-internal-capital-requirement ratio of at least 1.15 at the end of each year in the three-year plan. This is a company-specific planning objective in the case, not a universal regulatory standard. Executives expect the expansion to increase premium volume, but the product and distribution channel are new to Northstar.
The board does not need to make the ORSA calculations itself. It does need enough timely, reliable information to decide whether the proposed strategy is consistent with the insurer’s stated risk appetite and capital objectives, and to understand what management will do if it is not. The core governance question is therefore not simply, “Has an ORSA report been completed?” It is, “Can the right decision-makers trace the strategy, assumptions, risks, capital conclusions, and proposed responses to accountable owners?”
| Role | Governance contribution in this case | What the role does not replace |
|---|---|---|
| Board | Oversees the ORSA, challenges management’s conclusions, and uses the assessment when considering strategy and risk appetite. | Management’s responsibility to operate the business and prepare supportable analysis. |
| Chief executive and executive team | Own the management process, coordinate contributions, resolve disagreements, and bring decisions and material issues to the board. | The board’s oversight or the business units’ ownership of their operating assumptions. |
| Business and product leaders | Own relevant business plans, operational assumptions, and explanations of how proposed growth will be delivered. | Independent challenge or enterprise-wide coordination. |
| Risk function | Coordinates the risk-management perspective, challenges consistency with risk appetite, and helps bring material concerns to decision-makers. | Executive accountability for the business or board oversight. |
| Actuarial function | Provides actuarial analysis and professional challenge on relevant assumptions and conclusions. | Management ownership of the ORSA or business decisions. |
| Internal audit or another independent assurance function | Provides assurance, within its remit, about the design or operation of governance and controls. | Preparing or owning the assessment it later assesses. |
The allocation is not a rigid organization chart. A small insurer may combine functions, and responsibilities depend on its structure and applicable requirements. The essential point is that combining tasks does not erase the need to identify who is accountable, who provides challenge, and who receives and acts on escalated concerns.
Worked Example: Assigning Responsibility for a New Product
Worked Example: Assigning Responsibility for a New Product
Northstar’s product leader proposes the new commercial product. The actuary has reviewed the pricing assumptions, the risk function has identified concerns about concentration in a new distribution channel, and the chief executive wants to present a favorable ORSA conclusion. Assign the main responsibilities and state what the board should receive before deciding whether to approve the expansion.
Method. Separate the decision into ownership, analysis and challenge, executive accountability, and oversight. This avoids treating the department that performs a calculation as the owner of the business decision.
Step 1: Assign the business input. The product leader owns the proposed product plan and its operating assumptions, including the explanation of how the distribution arrangement is expected to generate business. The leader must explain the assumptions and respond to challenge; the leader cannot decide that the enterprise-level solvency conclusion is acceptable on the insurer’s behalf.
Step 2: Assign specialist contributions. The actuary contributes analysis of relevant actuarial assumptions and explains limitations or uncertainty. The risk function challenges whether the proposed concentration and growth are understood in relation to the insurer’s risk appetite. Neither function takes over the executive team’s responsibility to manage the business or make the recommendation.
Step 3: Assign executive accountability. The chief executive and executive team coordinate the assessment, resolve or disclose material differences in view, and present a recommendation supported by the underlying analysis. A favorable conclusion must follow from the evidence; it cannot be an instruction to specialists to suppress an unfavorable result.
Step 4: Specify the board’s decision information. Before deciding, the board should receive the strategic rationale, the important assumptions and their owners, the risk function’s challenge, the actuarial contribution and limitations, the implications for the capital objective, and management’s proposed response if the plan does not remain consistent with that objective. The board should also know which conclusions are unresolved and who is responsible for resolving them.
Check. The product leader owns the business plan, the actuary and risk function contribute and challenge within their roles, executives own the management process and recommendation, and the board oversees and challenges the decision. The common mistake is to make the actuary “responsible for ORSA” because actuarial analysis is prominent. The correction is to distinguish a technical contribution from ownership of the management process and strategic choice.
Board Challenge: Ask About Decisions, Not Just Documents
Board oversight is more effective when questions test the connection between the strategy and the assessment. A checklist of completed reports may confirm that materials exist, but it does not establish that assumptions were challenged or that conclusions affected a decision. Questions should expose the reasoning and accountability behind the recommendation.
- Strategic fit: What has changed in the plan, and why does management believe the expansion is consistent with the insurer’s risk appetite?
- Ownership: Who owns the assumptions about sales, underwriting, operations, and implementation? Who has challenged them?
- Capital objective: How does the plan affect the insurer’s stated capital objective over the planning horizon, and what explains any deterioration?
- Uncertainty: Which important conclusions depend on uncertain or new assumptions? What limitations should the board consider when relying on them?
- Decision and response: What choices are available if the plan is inconsistent with the objective, and who has authority to recommend or approve those choices?
- Escalation: What changes or concerns must management bring back to the board rather than treating as routine execution?
Challenge should be proportionate to the decision. A new product, a new distribution arrangement, or a substantial change in growth ambition may warrant closer attention than continuation of a familiar plan. That does not mean the board substitutes its judgment for every technical analysis. It means the board tests whether the analysis is decision-relevant, whether uncertainty and disagreement are visible, and whether the proposed action is within the authority and risk appetite the board has established.
Worked Example: Challenging a Growth Proposal
Northstar’s executives seek approval for the digital partnership. They report that projected premium volume is 30% higher than the existing plan, while the ORSA summary says only that “capital remains adequate.” The risk committee has not received the assumptions supporting the projection. Identify the governance gap and formulate three questions that would close it before the board makes a decision.
Method. Trace the claim from strategy to owned assumptions, then to the capital objective and an accountable decision. The percentage increase in premium volume is not, by itself, evidence of either adequate or inadequate capital.
Step 1: Identify what the reported information establishes. It establishes that management proposes a growth increase of 30% relative to the existing plan. It does not establish how the increase affects risks, the capital objective, or the insurer’s ability to manage the new channel. “Capital remains adequate” is a conclusion without the supporting link needed for board challenge.
Step 2: Ask about ownership and support. The board should ask, “Which business leader owns the premium-growth and implementation assumptions, and what evidence supports them?” This identifies the person accountable for the operating plan rather than treating the projection as an ownerless number.
Step 3: Ask about risk and capital implications. It should ask, “How does this plan change the assessment relative to the existing plan, and how does management demonstrate consistency with the board’s capital objective?” This requires a comparison and an explanation, not merely a repeated adequacy label.
Step 4: Ask about governance and action. It should ask, “What concerns did the risk function and other relevant reviewers raise, and what decision or escalation is proposed if the plan is not consistent with the objective?” This surfaces challenge and makes responsibility for follow-up explicit.
Conclusion. The gap is not simply a missing report; it is the absence of traceable support for a strategic conclusion. The common mistake is to treat higher premium volume as proof of success or to accept “adequate” as a self-explanatory result. The correction is to require an owned rationale connecting the proposed growth to risk, capital objectives, challenge, and a decision.
Connecting Capital Objectives to Strategic Governance
A capital objective becomes useful in governance when it affects choices. It should not be presented as a number disconnected from the business plan. In the case below, all figures are hypothetical and stated in millions of dollars. The ratio is a simple planning indicator supplied by the case; it is not a substitute for the insurer’s full ORSA analysis.
Worked Example: Applying Northstar’s Capital Objective
Northstar’s approved objective is a projected ratio of at least 1.15. Under the existing plan, projected capital is $180 million and projected internal capital requirement is $150 million. Under the proposed growth plan, the corresponding amounts are $198 million and $180 million. Determine whether the proposed plan meets the objective, and state the governance implication.
Method. Divide projected capital by projected internal capital requirement for each plan, then compare each ratio with the stated objective. The numerator and denominator must be taken from the same plan and projection point.
Existing plan. The ratio is \(180/150=1.20\). Since \(1.20\geq1.15\), the existing plan meets the stated objective by \(1.20-1.15=0.05\) ratio points.
Proposed growth plan. The ratio is \(198/180=1.10\). Since \(1.10<1.15\), the proposed plan does not meet the stated objective. The capital amount increased by \(198-180=18\) million dollars, but the internal capital requirement increased by \(180-150=30\) million dollars. Thus, higher projected capital alone does not establish consistency with the objective.
Governance implication. Management should not present the plan as meeting the approved objective on these figures. It should explain the result and bring forward a supported recommendation: for example, reconsider the growth plan or evaluate a proposed response through the insurer’s established governance process. The board must decide within its authority and receive a clear account of unresolved issues. No response should be credited merely because it is proposed; its feasibility and effect need support.
Check. The existing-plan ratio is 1.20, and the growth-plan ratio is 1.10, which is below the 1.15 objective. The common mistake is to focus on the $18 million increase in projected capital while overlooking that the requirement increased by $30 million. The correction is to compare the ratio, using matched figures, with the stated objective.
A Governance Derivation: Why Traceability Matters
The need for traceability follows from the logic of a governed decision. A board’s conclusion about a strategy depends on whether the strategy’s assumptions support the risk and capital conclusions, and whether those conclusions support the proposed action. If any link is missing, the board cannot reliably infer that the action follows from the analysis.
For example, if the projected growth assumption has no accountable business owner, the board cannot determine who must explain a material revision. If the capital conclusion is not related to the stated objective, the board cannot tell whether the recommendation satisfies that objective. If management’s response has no decision owner, the assessment may identify a concern without producing accountable action. Traceability therefore supports both challenge and follow-through; it is not merely a documentation preference.
State what management wants to do and how it changes the strategy.
Name who owns the business assumptions and who provides specialist analysis or challenge.
Show how the assessment informs the insurer’s stated risk appetite and capital objectives, including limitations or unresolved views.
Identify who recommends, who decides, what must be escalated, and who monitors the resulting action.
Common Governance Traps
- Confusing oversight with preparation. The board should challenge and oversee; it should not be assigned the executive task of constructing the assessment.
- Confusing expertise with ownership. Actuarial or risk expertise supports sound analysis, but does not transfer management accountability to those functions.
- Accepting an unsubstantiated adequacy statement. A conclusion needs a visible connection to assumptions, the capital objective, and the proposed decision.
- Allowing growth targets to override risk governance. A commercial target does not make an assessment favorable. Unfavorable results and disagreements must remain visible to decision-makers.
- Treating approval as the end of governance. The decision should have accountable follow-up, including escalation when relevant assumptions or circumstances change.
For Northstar, sound ORSA governance does not predetermine whether growth is desirable. It ensures that the people with operating knowledge own their inputs, specialists can provide candid analysis and challenge, executives make an accountable recommendation, and the board can judge that recommendation against the insurer’s objectives. That process makes ORSA part of strategic management rather than a report prepared after the important decisions have already been made.
Check Your Understanding
For each hypothetical case, identify the governance issue and the appropriate response.
- A business leader submits a growth forecast, but no one can explain who approved its operating assumptions. Who should own and explain those assumptions? (Answer: The responsible business leader should own and explain the business assumptions; executives coordinate the ORSA process and should not present the input as ownerless.)
- An actuary advises that a new product’s assumptions are uncertain. The chief executive says that this makes the actuary responsible for deciding whether to launch. What is the correction? (Answer: The actuary should communicate the analysis, uncertainty, and professional concerns; management remains accountable for the recommendation and business decision, subject to board oversight.)
- A hypothetical insurer has projected capital of $156 million and projected internal capital requirement of $130 million under a proposed plan. Its board-approved objective is a ratio of at least 1.15. Calculate the ratio and state whether it meets the objective. (Answer: \(156/130=1.20\); it meets the objective because \(1.20\geq1.15\).)
- A board receives a report stating that projected capital is $10 million higher than last year, but the report does not compare capital with the internal capital requirement or explain the strategic change. What should the board request? (Answer: A like-for-like explanation of the strategy and projections, the relationship of capital to the relevant requirement and approved objective, the accountable owners and challenge, and management’s recommendation.)
- A proposed partnership increases projected capital from $200 million to $220 million, while projected internal capital requirement increases from $160 million to $200 million. The objective is at least 1.15. Calculate both ratios and give the governance conclusion. (Answer: Before the partnership, \(200/160=1.25\); after it, \(220/200=1.10\). The proposed plan is below the objective, so management should explain the result and bring a supported recommendation through the established decision and escalation process; the increase in capital alone does not demonstrate that the objective is met.)